Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	31,532	35,528	56,595	59,667	28,552	14,022
Market Cap Growth	-45.35%	-37.22%	-5.15%	108.98%	103.62%	201.99%
Enterprise Value	38,370	45,350	62,791	63,025	30,523	15,593
Last Close Price	136.50	151.16	239.22	250.69	119.19	58.03
PE Ratio	61.57	68.19	111.01	63.81	33.08	36.83
PS Ratio	2.82	3.32	6.65	7.44	4.01	2.51
PB Ratio	4.89	5.83	9.52	10.04	5.33	3.03
P/TBV Ratio	4.81	5.86	9.54	10.04	5.33	3.03
P/OCF Ratio	88.06	-	91.11	55.14	145.26	48.16
EV/Sales Ratio	3.43	4.24	7.38	7.86	4.29	2.79
EV/EBITDA Ratio	-	19.25	41.92	30.64	17.47	18.46
EV/EBIT Ratio	19.22	24.80	64.13	38.97	22.41	46.76
EV/FCF Ratio	-81.87	-	-	-	-	-
Debt / Equity Ratio	1.58	1.69	1.25	0.64	0.47	0.47
Debt / EBITDA Ratio	-	4.38	4.98	1.86	1.43	2.58
Asset Turnover	0.64	0.64	0.67	0.83	0.91	0.93
Inventory Turnover	2.27	2.14	2.14	2.40	2.99	2.67
Quick Ratio	0.68	0.36	0.36	0.54	0.82	0.90
Current Ratio	1.44	1.37	1.20	1.38	1.87	1.84
Return on Equity (ROE)	8.02%	8.66%	8.58%	16.55%	17.29%	10.01%
Return on Assets (ROA)	7.18%	6.81%	4.81%	10.45%	10.83%	3.46%
Return on Capital (ROIC)	8.15%	7.67%	5.28%	11.47%	11.61%	3.60%
Earnings Yield	1.62%	1.47%	0.90%	1.57%	3.02%	2.72%
FCF Yield	-1.49%	-3.59%	-2.11%	-1.07%	-0.41%	-0.16%
Dividend Yield	1.47%	1.32%	0.67%	0.64%	1.26%	-
Payout Ratio	71.38%	70.93%	72.78%	39.95%	6.88%	15.23%
Total Shareholder Return	1.47%	1.32%	0.67%	0.64%	1.26%	-

Source: S&P Capital IQ. Standard template. Financial Sources.